The emergence of resistance to the antiparasitic selamectin in Mycobacterium smegmatis is improbable and contingent on cell wall integrity

ABSTRACT Tuberculosis remains the deadliest infectious disease of the 21st century. New antimicrobials are needed to improve treatment outcomes and enable therapy shortening. Drug repurposing is an alternative to the traditional drug discovery process. The avermectins are a family of macrocyclic lac...

Full description

Saved in:
Bibliographic Details
Main Authors: José Manuel Ezquerra-Aznárez, Henrich Gašparovič, Álvaro Chiner-Oms, Ainhoa Lucía, Jesús Blázquez, Iñaki Comas, Jana Korduláková, José A. Aínsa, Santiago Ramón-García
Format: Article
Language:English
Published: American Society for Microbiology 2025-05-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02332-24
Tags: Add Tag
No Tags, Be the first to tag this record!